Induction of interleukin-12 production in chronic hepatitis C virus infection correlates with the hepatocellular damage.

Interleukin (IL)-12 plays an essential role in host defense against infectious diseases. Serum IL-12 concentration and blood mononuclear cell production with or without specific interferon (IFN)-gamma priming were investigated in 65 chronic hepatitis C virus (HCV) patients and 25 healthy donors. HCV patients had higher serum IL-12 levels (P = .004) and produced higher amounts after IFN-gamma priming (P < .001) than donors. A subset of patients did not produce IL-12: They had lower serum levels (P = .032) and showed signs of liver piecemeal necrosis less frequently (P = .011). Patients with greater liver necroinflammatory activity produced more IL-12 than patients with minimal or mild activity and donors (P < .01). During IFN-alpha therapy for 16 HCV patients, individuals with end-of-treatment alanine aminotransferase normalization and clearance of viremia had higher serum levels and produced more IL-12 than those who did not (P < .05). These results suggest a role for IL-12 in the immunopathogenesis and outcome of HCV infection.

[1]  J. Hoofnagle,et al.  THE TREATMENT OF CHRONIC VIRAL HEPATITIS , 1997 .

[2]  Neil Kaplowitz,et al.  Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis , 1981, Hepatology.

[3]  C. Rice,et al.  Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients , 1996, Journal of virology.

[4]  R. Williams,et al.  Interleukin-12 induction of Th1 cytokines is important for viral clearance in chronic hepatitis B. , 1997, The Journal of clinical investigation.

[5]  M. Gately,et al.  Interleukin 12 at the site of disease in tuberculosis. , 1994, The Journal of clinical investigation.

[6]  G. Riethmüller,et al.  Mapping of immunodominant CD4+ T lymphocyte epitopes of hepatitis C virus antigens and their relevance during the course of chronic infection , 1995, Hepatology.

[7]  C. Rice,et al.  The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C. , 1997, Journal of immunology.

[8]  T. Ishikawa,et al.  Production of interleukins 10 and 12 by peripheral blood mononuclear cells (PBMC) in chronic hepatitis C virus (HCV) infection , 1997, Clinical and experimental immunology.

[9]  G. Trinchieri,et al.  Impaired interleukin 12 production in human immunodeficiency virus- infected patients , 1994, The Journal of experimental medicine.

[10]  G. Trinchieri,et al.  Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. , 1994, Blood.

[11]  M. Norcross,et al.  Regulation of interleukin-12 expression in human monocytes: selective priming by interferon-gamma of lipopolysaccharide-inducible p35 and p40 genes. , 1995, Blood.

[12]  J. Hoofnagle,et al.  Classification of chronic hepatitis: Diagnosis, grading and staging , 1994, Hepatology.

[13]  C. Ferrari,et al.  T‐cell response to structural and nonstructural hepatitis C virus antigens in persistent and self‐limited hepatitis C virus infections , 1994, Hepatology.

[14]  J. Hoofnagle,et al.  The treatment of chronic viral hepatitis. , 1997, The New England journal of medicine.